Industry

DUBLIN–(BUSINESS WIRE)–The “Global Asthma Warning Sensors Market, By Type (Wearable v/s Non-Wearable), By Technology (AI, IoT, Machine Learning, Others), By Parameter Measured (FEV1 v/s Peak Flow), By End User, By Region, Competition Forecast and Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Global asthma warning sensors market is expected to show robust growth with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Breast Pumps: Global Markets” report has been added to ResearchAndMarkets.com’s offering. This report aims to provide a comprehensive study of the global market for breast pumps. It describes the different types of breast pumps used for feeding newborns and their current and historical market revenues. Growth in this market is by the rising … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the pricing of an underwritten public offering of 30,500,000 shares of its common stock at a price to the public of $1.15 per share, before underwriting discounts and commissions. The gross proceeds to Biodesix … [Read more…]

Practical Application of Cancer Species Specific Tests for Nematode Cancer Testing － Pre-orders open today. Special pricing applies during the pre-order period. － TOKYO–(BUSINESS WIRE)–HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu; hereafter referred to as “HIROTSU”) is pleased to announce the commercialization of “N-NOSE plus Pancreas,” the first next-generation “cancer type … [Read more…]

AUCKLAND, New Zealand–(BUSINESS WIRE)–Pictor, a global leader in immunodiagnostics, today announced that its PictArray™ SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test will soon be available in New Zealand. Rako Science will utilize its national network by collecting blood samples with a device from Tasso, Inc., and undertake testing for COVID-19 antibodies. Pictor’s COVID-19 antibody … [Read more…]

Cooperation for the Establishment of the Precision Medicine Research Platform at SNUBH Biomedical Research Institute SAN JOSE, Calif.–(BUSINESS WIRE)–Seoul National University (SNU) Bundang Hospital Biomedical Research Institute announced that it concluded the MOU on November 15, 2022, to standardize clinico genomic research using Cipherome, Inc.’s precision medicine research platform at Precision Medicine Center. Precision Medicine … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–Owens & Minor, Inc. (NYSE: OMI) announced today that executive leadership will participate in a virtual fireside chat at the upcoming 5th Annual Evercore ISI HealthCONx Conference. The discussion will take place on Wednesday, November 30 at 1:00 p.m. Eastern Time. Please visit the investor relations page of the Owens & Minor website … [Read more…]

WILIMINGTON, Del.–(BUSINESS WIRE)–Phreesia is proud to announce that Sara DiNardo, the company’s Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2022. Honorees were chosen based on their demonstrated leadership capabilities, career track record and quantifiable contributions to the Software-as-a-Service industry. This … [Read more…]

Study of the Verve RPD™ Renal Pelvic Denervation System Shows 20.3 mm Hg Reduction in Blood Pressure in Patients with Uncontrolled Hypertension PHOENIX–(BUSINESS WIRE)–Verve Medical, Inc. (“Verve”) today announced the detailed results from a feasibility trial evaluating a novel ablation therapy that achieved therapeutically significant blood pressure (“BP”) reduction for 100% of treated patients with … [Read more…]

Company to provide industry perspective on the use of emerging blood-based biomarkers tests in Alzheimer’s disease clinical trials. BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced plans to participate in the upcoming 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force in San Francisco, California from … [Read more…]